Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Depreciation and Depletion (2023 - 2024)

Moolec Science (MLECW) posted Depreciation and Depletion of -$5032.0 for Q3 2024, down 100.09% sequentially from $5.8 million in Q2 2024, and down 150.86% YoY from $9894.0 in Q4 2023.

Moolec Science (MLECW) Depreciation and Depletion (2023 - 2024) Analysis & Trends

Moolec Science has reported Depreciation and Depletion for 2 years, with the latest figure at -$5032.0 in Q3 2024.

  • Quarterly Depreciation and Depletion fell 150.86% year-over-year to -$5032.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $5.8 million (changed N/A YoY) and the FY2025 annual result came in at $6.0 million, up 3.72% from the prior year.
  • Depreciation and Depletion eased to -$5032.0 in Q3 2024 per MLECW's latest filing, from $5.8 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $5.8 million in Q2 2024 and troughed at -$6646.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 50,804.00
Dec 31, 2024 50,804.00
Sep 30, 2024 -5,032.00
Sep 30, 2024 -5,032.00
Jun 30, 2024 5.81 Mn
Jun 30, 2024 5.81 Mn
Mar 31, 2024 -6,646.00
Mar 31, 2024 -6,646.00
Dec 31, 2023 -2,230.00
Dec 31, 2023 -2,230.00
Sep 30, 2023 9,894.00
Sep 30, 2023 9,894.00
Jun 30, 2023 4.94 Mn
Jun 30, 2023 4.94 Mn
Mar 31, 2023 425.00
Mar 31, 2023 425.00